Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Farxiga (dapagliflozin) typically costs around $600 to $700 per month at retail for a 30-day supply of 5 mg or 10 mg tablets, though what you actually pay varies widely based on insurance, pharmacy, and dosage. Several factors can lower the price, including manufacturer savings cards, patient assistance programs, prescription discount coupons, 90-day supply fills, mail-order pharmacies, Medicare Part D coverage tiers, and newly available generic dapagliflozin in some markets. There are important details to consider, such as eligibility restrictions on savings programs and how prior authorization can affect your out-of-pocket cost. See below to understand more about which options may apply to your situation.
If you are weighing the cost of Farxiga, it helps to first be clear on what you are treating and whether your current symptoms need attention, since that shapes which medications, dosages, and coverage pathways make sense for you. Take a free, instant, online symptom check to better understand what may be going on and to feel more prepared for your next conversation with a doctor or pharmacist.
Last reviewed for medical accuracy: 09/24/2026
Farxiga (dapagliflozin) is a prescription medication used primarily to:
It belongs to a class of drugs called SGLT2 inhibitors, which work by helping the kidneys remove glucose through the urine.
The retail sticker price for a 30-day supply of Farxiga (10 mg once daily) generally ranges from $550 to $750 in the United States without insurance. Costs can vary widely based on:
For example, some online pharmacies list:
Keep in mind these are cash prices. If you have insurance or qualify for assistance, your out-of-pocket cost may be much lower.
Insurance Coverage
Pharmacy Choice
Dosage and Supply Size
Generic Availability
AstraZeneca, the maker of Farxiga, often offers a copay assistance card for eligible commercially insured patients, which can reduce your copay to as little as $0–$25 per month. Key points:
If you’re uninsured or underinsured, AstraZeneca’s Patient Assistance Program may help:
Contact the program directly or ask your healthcare team to help you apply.
Websites and apps like GoodRx (no direct link here) can show current coupons:
Purchasing a 90-day supply via mail order or a specialty pharmacy can:
Confirm with your insurer that they cover a 90-day prescription before ordering.
As generic dapagliflozin becomes more widely available:
It’s important to discuss any new or worsening symptoms—like dehydration, dizziness, or urinary tract infections—with a healthcare provider promptly. If you’re unsure whether your symptoms are related to Farxiga or another condition, you might try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help guide your next steps.
Managing the farxiga cost doesn’t have to be overwhelming. By combining insurance benefits, manufacturer assistance, generic options, and savvy pharmacy shopping, many people reduce their out-of-pocket expenses significantly.
Always:
Your health and budget both matter—work with your healthcare team to find the best balance.
(References)
* Johnston R, Uthman O, Cummins E, Clar C, Royle P, Colquitt J, Tan BK, Clegg A, Shantikumar S, Court R, O'Hare JP, McGrane D, Holt T, Waugh N. Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation. Health Technol Assess. 2017 Jan;21(2):1-218. doi: 10.3310/hta21020. PMID: 28105986; PMCID: PMC5292646.
* Ertugliflozin for type 2 diabetes. Med Lett Drugs Ther. 2018 Apr 23;60(1545):70-72. PMID: 29667948.
* Abdelhamid M, Elsisi GH, Seyam A, Shafie A, Kirollos M, Emad S, Mansy S, Sobhy M. Dapagliflozin cost-effectiveness analysis in heart failure patients in Egypt. J Med Econ. 2022 Jan-Dec;25(1):450-456. doi: 10.1080/13696998.2022.2054226. PMID: 35291896.
* McEwan P, Darlington O, Miller R, McMurray JJV, Wheeler DC, Heerspink HJL, Briggs A, Bergenheim K, Garcia Sanchez JJ. Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease: A Health-Economic Analysis of DAPA-CKD. Clin J Am Soc Nephrol. 2022 Dec;17(12):1730-1741. doi: 10.2215/CJN.03790322. Epub 2022 Nov 2. PMID: 36323444; PMCID: PMC9718008.
* Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD. Population-Wide Screening for Chronic Kidney Disease : A Cost-Effectiveness Analysis. Ann Intern Med. 2023 Jun;176(6):788-797. doi: 10.7326/M22-3228. Epub 2023 May 23. PMID: 37216661; PMCID: PMC11091494.
* Tang Y, Sang H. Cost-utility analysis of add-on dapagliflozin in heart failure with preserved or mildly reduced ejection fraction. ESC Heart Fail. 2023 Aug;10(4):2524-2533. doi: 10.1002/ehf2.14426. Epub 2023 Jun 8. PMID: 37290665; PMCID: PMC10375078.
* Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD, Salomon JA. When to Start Population-Wide Screening for Chronic Kidney Disease: A Cost-Effectiveness Analysis. JAMA Health Forum. 2024 Nov 1;5(11):e243892. doi: 10.1001/jamahealthforum.2024.3892. Epub 2024 Nov 1. PMID: 39514193; PMCID: PMC11549659.
* Kokkorakis M, Chakhtoura M, Rhayem C, Al Rifai J, Ghezzawi M, Valenzuela-Vallejo L, Mantzoros CS. Emerging pharmacotherapies for obesity: A systematic review. Pharmacol Rev. 2025 Jan;77(1):100002. doi: 10.1124/pharmrev.123.001045. Epub 2024 Nov 22. PMID: 39952695.
* Zampieri FG, Azevedo LCP, Neto AS, Rea-Neto Á, David-João PG, Amendola CP, Kozesinski-Nakatani AC, Filiponi TC, Almeida GMB, Bergo RR, Figueiredo RC, Schuler CJ, Westphal GA, Biondi RS, Pereira AJ, Correa TD, Berwanger O, Bagshaw SM, Bellomo R, Tavares CAM. Effects of dapagliflozin on urinary output, fluid balance, and biochemistry in critically ill patients: a post-hoc secondary analysis of the DEFENDER trial. Crit Care. 2025 Jul 11;29(1):297. doi: 10.1186/s13054-025-05534-0. Epub 2025 Jul 11. PMID: 40646628; PMCID: PMC12247443.
* Qiu T, Li P, Yan D. Cost-Effectiveness of Adding Dapagliflozin and Empagliflozin to Standard Treatment for Diabetic Kidney Disease in China. Clin Drug Investig. 2025 Sep;45(9):651-664. doi: 10.1007/s40261-025-01462-7. Epub 2025 Jul 14. PMID: 40658333.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.